Study authors include: Karen J. Coleman, PhD, Corinna Koebnick, PhD, and Ning Smith, PhD, from the Southern California Permanente Medical Group, Department of Research & Evaluation, Pasadena, Calif.; Ana F. Alpern, MD, Brenna Bley, DO, Marianne Yousef, MD, Erin M. Shih, MD, Keila J. Trimble-Cox, MD, Amy H. Porter, MD, and Steven D. Woods, MD, MSPH, from the Department of Pediatrics, Kaiser Permanente Southern California, Los Angeles; and Anne C. Hsii, MD, from the Division of Adolescent Medicine, Stanford University School of Medicine, Stanford, Calif.
About the Kaiser Permanente Department of Research & Evaluation
The Department of Research & Evaluation (R & E) conducts high-quality, innovative research into disease etiology, prevention, treatment and care delivery. Investigators conduct epidemiology, health sciences, and behavioral research as well as clinical trials. Areas of interest include diabetes and obesity, cancer, HIV/AIDS, cardiovascular disease, aging and cognition, pregnancy outcomes, women's and children's health, quality and safety, and pharmacoepidemiology. Located in Pasadena, Calif., the department focuses on translating research to practice quickly to benefit the health and lives of Kaiser Permanente Southern California members and the general population. Visit www.kp.org/research.
About Kaiser Permanente
Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America's leading health care providers and not-for-profit health plans. Founded in 1945, our mission is to provide high-quality, affordable health care services and to improve the health of our members and the communities we serve. We currently serve 8.9 million members in nine states and the District of Columbia. Care for members and patients is focused on their total
|SOURCE Kaiser Permanente|
Copyright©2010 PR Newswire.
All rights reserved